What's breaking now, across thousands of outlets.
(MedPage Today) -- Liver transplant patients who took a GLP-1 receptor agonist had a lower risk of death than those who weren't on a GLP-1 drug, according to a retrospective three-center cohort study. Among 2,402 patients, those on GLP-1 receptor...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
This story was initially published in Healthbeat, public health, explained. Sign up to receive Healthbeat’s free New York City newsletter here .
Seasonal affective disorder can affect mood, energy and sleep during the winter months.
A dietary supplement called urolithin A increased blood flow to the brain during mental activity in middle-aged adults with obesity, according to a University of Oklahoma study published in JAMA…
Learn the surprising similarities between different people’s experiences of death — and why there’s still so much we don’t know about it all.
Key PointsEli Lilly is one of the undisputed leaders in the weight loss market, and its progress in this area is helping it deliver excellent financial results.
Researchers at the Francis Crick Institute have tested thousands of possible BRCA1 mutations in mammary gland cells to shed light on which genetic variants confer a high risk of developing breast…
